Skip to content
Review Open access

One team, one visit: Reducing time to treatment through a multidisciplinary clinic in rectal cancer.

Oct 2026 · JCO Oncology Practice · 0 citations

Abstract

66 Background: Timely treatment is a key quality metric in rectal cancer care. Because treatment planning requires input from medical, surgical, and radiation oncology, delays may occur when consultations are conducted separately. Multidisciplinary clinics (MDCs) provide coordinated specialty evaluation and collaborative treatment planning within a single visit. We assessed whether MDC evaluation was associated with earlier treatment initiation. Methods: We performed a retrospective review of patients with newly diagnosed stage I-III rectal cancer at Beth Israel Lahey Health from 10/2024-11/2025. MDC participation was defined as an initial visit by ≥2 oncology specialists. Chart review determined dates of diagnosis, clinic evaluation, and treatment initiation; 10% underwent dual review to ensure inter-rater reliability. Baseline demographic and clinical characteristics were compared. Results: 107 patients met inclusion; 28 MDC and 79 non-MDC patients. Demographic characteristics were similar between groups except MDC patients were more racially diverse, more likely to live in a zip code associated with a Social Vulnerability Index >0.75, and more likely to have stage II/III cancer. Median age was 64.5 (IQR 52.3-72.8) and 57% were male overall. MDC patients demonstrated shorter intervals from diagnosis to first provider evaluation (12.5 vs 17 days) and from first provider evaluation to treatment initiation (23.5 vs 28 days). Median time from diagnosis to treatment initiation was 36.5 days (IQR 27.8-42.3) among MDC vs. 48 days (IQR 33.5-66) among non-MDC patients, representing an 11.5-day reduction in time to treatment. Variability in treatment initiation was lower among MDC patients, with a narrower interquartile range (14.5 vs 32.5 days). Conclusions: MDC participation was associated with faster and more consistent treatment initiation for patients with rectal cancer than traditional sequential consultations, despite serving a more socially vulnerable and clinically complex population. These findings support MDC as an effective model for rectal cancer management and suggest that dedicated care coordination resources may further improve treatment delivery. MDC Patients Median days (IQR) Non-MDC Patients Median days (IQR) Diagnosis to first provider appointment 12.5 days (8-19.8) 17 days (8-29) First provider appointment to first treatment 23.5 days (18.3-26) 28 days (19-41.5) Diagnosis to first treatment 36.5 days (27.8-42.3) 48 days (33.5-66)

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.